Hematology/Oncology

Top Story

Few rheumatic adverse events from immune checkpoint inhibitors require discontinuation

November 15, 2018
In the Journals Plus

Adolescent obesity linked to increased risk for pancreatic cancer

November 15, 2018
Obesity during adolescence appeared associated with a fourfold increased risk for pancreatic cancer later in life, according to an analysis of 1.7 million Israeli Jewish…
Meeting News

Proton therapy for pediatric brain tumors yields better cognitive outcomes than X-ray therapy

November 15, 2018
Proton therapy appeared associated with better neuropsychological outcomes than X-ray radiation therapy among children with brain tumors, according to a study presented…
Meeting News

AMA affirms medical spectrum of gender

November 15, 2018
During the AMA Interim Meeting, delegates adopted several new policies on important emerging health care topics, including gender identity. In October, The New York
Meeting News

AMA adopts policy supporting in-person importation of prescription drugs from Canada

November 15, 2018
To address concerns that out-of-pocket costs for prescription drugs have reduced access to essential medications, delegates at the Interim Meeting of the AMA adopted a…
More Headlines »
CME CPE CNE

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Video
Meeting News

VIDEO: Take homes from GI Outlook: Leadership, MACRA, burnout

August 20, 2018
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

CME ABIM MOC

Ace the Case: A 55-Year-Old Woman With an Oddly-Shaped, Raised Pigmented Lesion on Right Thigh

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case-based approach in a 55-year-old woman to discuss the diagnosis and…
More »
Current Issues
View the Current Issue
HemOnc Today